Silent Scourge: Antimicrobial Resistance and India’s Social Equity

Antimicrobial Resistance (AMR) is a global health crisis, often described as a ‘silent pandemic,’ where microorganisms evolve to resist drugs designed to kill them. In India, this challenge is particularly acute, deeply intertwined with the nation’s diverse social fabric, healthcare access disparities, and environmental factors. As of 2026, the implications of AMR are becoming increasingly visible, threatening to reverse decades of progress in public health and medicine. It jeopardizes our ability to treat common infections, perform routine surgeries, and manage chronic diseases, disproportionately impacting vulnerable populations. This growing resistance renders once-effective antibiotics, antivirals, antifungals, and antiparasitics useless, turning treatable infections into deadly threats.

AMR is not merely a biological phenomenon but a complex socio-ecological problem demanding an integrated societal response.

The rise of superbugs capable of evading multiple drug classes underscores the urgency of addressing this crisis from a social justice perspective.

The proliferation of AMR in India stems from a confluence of structural and institutional deficiencies. A significant cause is the widespread and often unregulated use and misuse of antibiotics in human health, livestock, and agriculture. Over-the-counter sales without prescriptions, incomplete dosages, and self-medication are rampant, driven by low health literacy and economic constraints. Poor sanitation and hygiene practices, especially in densely populated urban slums and rural areas, facilitate the rapid spread of resistant pathogens. Inadequate wastewater treatment from pharmaceutical manufacturing units further contaminates water bodies, creating reservoirs for resistant bacteria. Furthermore, weak regulatory frameworks and enforcement regarding antibiotic usage, coupled with limited surveillance infrastructure, contribute significantly. The lack of investment in research and development for new antimicrobial agents, alongside the global economic disincentives for pharmaceutical companies, exacerbates the problem, leaving a critical gap in our therapeutic arsenal.

The societal implications of AMR are profound and far-reaching. Firstly, it leads to increased morbidity and mortality, making common infections untreatable and significantly raising healthcare burdens on individuals and the public health system. Economically, AMR results in prolonged hospital stays, higher treatment costs, and loss of productivity, pushing many families into poverty and exacerbating existing social inequalities. From a social justice perspective, marginalized communities, who often lack access to quality healthcare, clean water, and sanitation, bear the brunt of AMR. They are more exposed to resistant pathogens and less equipped to afford expensive second or third-line treatments. The erosion of trust in modern medicine, particularly among the poor who witness treatment failures, is another critical social consequence. Moreover, AMR threatens the foundational pillars of modern medicine, making complex surgeries, organ transplants, and cancer chemotherapy dangerously risky, impacting the overall quality of life and human development.

India has recognized the gravity of AMR and initiated several responses. The National Action Plan on Antimicrobial Resistance (NAP-AMR) 2017-2021 (now being updated for a new phase) adopted a ‘One Health’ approach, acknowledging the interconnectedness of human, animal, and environmental health. Key strategies include strengthening surveillance, promoting rational use of antibiotics, improving infection prevention and control, and fostering research. Regulatory measures, such as the classification of certain antibiotics under Schedule H1 to restrict over-the-counter sales, have been implemented. Campaigns like the “Red Line campaign” aim to raise public awareness about the judicious use of antibiotics. India also actively participates in global forums, advocating for collective action against AMR. However, implementation remains a challenge, requiring stronger inter-sectoral coordination and sustained resource allocation. Discussions around strengthening healthcare financing and resource allocation, as highlighted by bodies like the 16th Finance Commission, are crucial for bolstering public health infrastructure to combat AMR effectively. For more on how resource distribution impacts critical sectors, read about Reimagining Fiscal Federalism: The 16th Finance Commission’s Mandate.

Addressing AMR effectively necessitates a multi-pronged, innovative approach. Firstly, there is an urgent need for accelerated research and development into new antibiotics, rapid diagnostic tools, and alternative therapies such as phage therapy. Encouraging public-private partnerships and offering incentives for pharmaceutical innovation can revive the stagnant antibiotic pipeline. Secondly, robust national and sub-national surveillance systems, leveraging advanced data analytics and artificial intelligence, are crucial for real-time tracking of resistance patterns. Thirdly, a comprehensive ‘One Health’ strategy must be strengthened, integrating human, animal, and environmental health sectors. This includes regulating antibiotic use in livestock and aquaculture, improving biosecurity, and investing in advanced wastewater treatment. Behavioural change communication strategies, tailored to diverse socio-cultural contexts, are essential to promote responsible antibiotic use and hygiene practices among the public. Finally, global collaboration, perhaps through expanded platforms like BRICS, is vital for sharing knowledge, resources, and developing common regulatory standards to tackle this transnational threat. The future calls for sustained investment and a societal shift towards prevention and responsible usage. Such collaborative frameworks are essential, mirroring the discussions around Expanded BRICS: Reshaping Global Governance and Multipolarity’s Future in addressing global challenges.

From a sociological lens, AMR is a vivid illustration of health inequality and social stratification. Vulnerable groups, including the poor, migrant workers, and those in remote areas, face higher exposure risks due to inadequate sanitation, lack of clean water, and limited access to qualified medical professionals. This leads to reliance on informal healthcare providers and over-the-counter medication, fostering misuse. Cultural practices, such as seeking quick symptomatic relief or traditional beliefs impacting adherence to medical advice, also play a role. The crisis exposes systemic failures in public health infrastructure and governance, revealing how social determinants of health amplify biological threats. AMR thus becomes a critical issue of social justice, demanding equitable access to effective healthcare and prevention strategies, challenging existing power structures that perpetuate health disparities.

The fight against AMR is deeply rooted in India’s constitutional framework, particularly the Right to Life (Article 21), which implicitly includes the Right to Health. The State’s failure to control AMR effectively can be seen as a violation of this fundamental right, as it directly impacts citizens’ ability to live a life with dignity and access necessary medical care. Furthermore, Directive Principles of State Policy (DPSP), especially Article 47, which mandates the State to improve public health and the standard of living, places a clear obligation on the government to combat AMR. Ensuring access to clean water and sanitation (also linked to Article 21 and 21A), crucial for AMR prevention, falls within this ambit. A robust legal and policy framework is required to uphold these rights, ensuring equitable access to effective antimicrobial treatments and preventive measures, especially for marginalized sections of society.

As of April 2026, the global dialogue on AMR continues to intensify, with WHO reports consistently highlighting India as a hotspot for drug-resistant infections. Recent data from the Indian Council of Medical Research (ICMR) indicates a concerning rise in resistance to last-resort antibiotics, particularly in hospital settings, prompting renewed calls for stringent infection control. The government has recently launched a national awareness campaign focusing on the ‘One Health’ approach, emphasizing responsible antibiotic use in both human and animal health sectors. There’s also growing interest in leveraging genomic surveillance and AI-powered predictive models to track new resistance genes. Discussions within the G20 and BRICS nations often include AMR as a priority area for collaborative research, funding, and policy harmonization, recognizing it as a shared global public good challenge demanding collective solutions beyond national borders.

1. Discuss how Antimicrobial Resistance (AMR) exacerbates existing social inequalities and challenges India’s pursuit of social justice. (15 marks)
2. Critically analyze the structural and institutional factors contributing to the widespread prevalence of AMR in India. Suggest innovative solutions. (15 marks)
3. Examine the ‘One Health’ approach in combating AMR. How effectively has India integrated this approach into its public health strategy? (10 marks)
4. To what extent does the rise of AMR pose a threat to the Right to Life (Article 21) in India? Elaborate with suitable examples. (10 marks)
5. “AMR is not just a medical problem but a sociological challenge.” Justify this statement in the Indian context, highlighting its impact on various social groups. (15 marks)

This topic primarily maps to GS-I: Salient features of Indian Society, Social empowerment, Social problems and their remedies. It also touches upon GS-II: Issues relating to development and management of Social Sector/Services relating to Health, and GS-III: Science and Technology- developments and their applications and effects in everyday life; Indigenization of technology and developing new technology.

5 Key Ideas:
1. AMR as a ‘silent pandemic’ with socio-economic repercussions.
2. ‘One Health’ approach for integrated human, animal, environmental health.
3. AMR as a critical social justice and equity issue.
4. Role of behavioral change communication in prevention.
5. Need for global collaboration and R&D incentives.

5 Key Sociological Terms:
1. Social Stratification
2. Health Inequality
3. Medical Pluralism
4. Social Determinants of Health
5. Trust in Institutions

5 Key Issues:
1. Unregulated antibiotic sales and misuse.
2. Poor sanitation and hygiene.
3. Lack of investment in new drug R&D.
4. Weak surveillance and regulatory enforcement.
5. Environmental contamination from pharmaceutical waste.

5 Key Examples:
1. Rise of carbapenem-resistant enterobacteriaceae (CRE) in Indian hospitals.
2. Self-medication practices prevalent in rural and urban informal sectors.
3. Antibiotic use in poultry farming and aquaculture.
4. Ganga river studies showing high levels of antibiotic-resistant bacteria.
5. Increased patient costs for treating drug-resistant Tuberculosis (DR-TB).

5 Key Facts/Data:
1. WHO projects 10 million deaths annually globally by 2050 due to AMR if unchecked.
2. India is among the top consumers of antibiotics globally.
3. ICMR studies consistently show high rates of resistance to common antibiotics.
4. AMR could lead to a global GDP loss of 3.8% annually by 2050.
5. Only a handful of new antibiotic classes have been discovered since the 1980s.